Teladoc Health, Inc. Securities Fraud LawsuitTeladoc Health, Inc. Securities Fraud Lawsuit July 10, 2024 – Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder has filed a class action lawsuit on behalf of all purchasers of Teladoc Health, Inc. (NYSE: TDOC) common stock between November 2, 2022 and February 20, 2024. Allegations: The lawsuit alleges that Teladoc Health, Inc. misled investors regarding its business activities. Specifically, the defendants are accused of making false and/or misleading statements and failing to disclose that: * Teladoc continued to increase its marketing spending in 2023 despite public assurances that it would reduce its advertising spending. * Increased marketing spending on BetterHelp, an online counseling service, eroded Teladoc’s revenues with little return on investment. * Despite acknowledging that increased advertising spending would be inefficient due to market saturation, Teladoc continued to increase its advertising on the BetterHelp business. * Contrary to public assurances of “a long runway” for BetterHelp membership growth, BetterHelp membership stagnated and declined in 2023 due to market saturation and BetterHelp’s own marketing. What’s Next: Investors who purchased Teladoc Health, Inc. common stock during the Class Period may be eligible to join the class action. The deadline to file a motion to be appointed as lead plaintiff is July 16, 2024. Contact: The Law Firm of Rosen, PA Laurence Rosen, Esq. Philip Kim, Esq. 275 Madison Avenue, 40th Floor New York, NY 10016 Phone: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] www.rosenlegal.com Legal Notice: Lawyer Advertisement. Previous results do not guarantee a similar outcome. All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
NEW YORK, July 10, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder has filed a class action lawsuit on behalf of all purchasers of Teladoc Health, Inc. (NYSE: TDOC) common stock between November 2, 2022 And February 20, 2024Shareholders wishing to act as lead plaintiffs for the class must file their motions with the Court no later than March 15, 2019. July 16, 2024.
To join the Teladoc class action, go to https://rosenlegal.com/submit-form/?case_id=6818 or call Philip Kim, Esq. call toll free at 866-767-3653 or email [email protected].
The Rosen Law Firm is investigating allegations that Teladoc Health, Inc. (NYSE: TDOC) misled investors regarding its business activities.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Teladoc continued to increase its marketing spending in 2023 despite public assurances that it would reduce its advertising spending; (2) increased marketing spending on BetterHelp, a division of the company and online counseling service, eroded Teladoc’s revenues, with little return on that investment; (3) despite Teladoc’s acknowledgement that increased advertising spending would be marginally inefficient due to market saturation, it continued to increase its advertising spending on the BetterHelp business; and (4) despite public assurances that there was “a long runway” for BetterHelp membership growth, BetterHelp membership stagnated and then declined in 2023 due to market saturation, largely due to BetterHelp’s own marketing. When the true details emerged, the lawsuit alleges investors suffered damages.
What’s Next: You may be eligible to join the class action against Teladoc Health, Inc. The deadline to file a motion to be appointed as lead plaintiff is July 16, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for compensation. If you choose not to take action, you may remain an absent class member. For more information, visit https://rosenlegal.com/case/teladoc-health-inc/
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
Lawyer Advertisement. Previous results do not guarantee a similar outcome.
Contact details:
Laurence Rosen, Esq.
Philip Kim, Esq.
The Law Firm of Rosen, PA
275 Madison Avenue, 40th Floor
New York, NY 10016
Phone: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/tdoc-investors-have-opportunity-to-lead-teladoc-health-inc-securities-fraud-lawsuit-302193803.html
SOURCE THE ROSEN LAW FIRM, PA
